Yesterday
Navis Capital’s Device Tech rules off $400m debt deal
Street Talk understands the $400 million was underwritten by Commonwealth Bank and Westpac last week.
- Sarah Thompson, Kanika Sood and Emma Rapaport
This Month
Ding ding! Round two under way for $500 million-plus Cura auction
The $11.4 billion private hospital operator looks at plenty of deals and isn’t likely to get into a sword fight with overzealous private equity.
- Sarah Thompson, Kanika Sood and Emma Rapaport
Myhealth founder closes in on Crescent’s home doctor business
It is understood James Liang is working with MA Financial Australia on his tilt for 24-7 Healthcare.
- Sarah Thompson, Kanika Sood and Emma Rapaport
Medibank eyes larger MyHealth stake as founder looks for the exit
Street Talk understands the $9.7 billion ASX-listed private health insurance giant will become Myhealth’s largest shareholder
- Sarah Thompson, Kanika Sood and Emma Rapaport
- Exclusive
- Medicare
GenesisCare breaches divide local cancer services industry
The company has told investors that its failure to offer bulk billing after accepting government funding for cancer care equipment is an industry-wide issue.
- Carrie LaFrenz and Jemima Whyte
Carlisle Health snaps up rival radiologist; monitors for sale symptoms
Sources who spoke to Street Talk reckon Carlisle Health will add a handful more practices before selling the group next year.
- Sarah Thompson, Kanika Sood and Emma Rapaport
This simple exercise burns 800 calories – and slashes your heart attack risk
A new study of more than 450,000 UK adults has found that simply climbing the stairs can burn calories and body fat, slashing the risk of a heart attack.
- Jessica Salter
Perennial fundie’s top small-cap healthcare picks
Perennial portfolio manager Damian Cottier has increased the fund’s stake in Calix and shares why he likes Immutep.
- Joanne Tran
Bain Capital-backed Estia in $400m-plus BlueCross auction
Corporate advisor Canterbury Partners has been tapped to run the auction and received indicative bids over the weekend.
- Sarah Thompson, Kanika Sood and Emma Rapaport
Ramsay Health Care pops up in $500 million-plus Cura auction
ASX-listed Ramsay submitted a non-binding indicative bid to sell-side adviser Citi.
- Sarah Thompson, Kanika Sood and Emma Rapaport
Eucalyptus ups capital raising with $8m second close
The raise predates the Medical Board of Australia cracking down on telehealth prescribing via text, taking its latest funding round to almost $60 million.
- Nick Bonyhady
September
- Exclusive
- Start-ups
Ozempic-selling start-up Eucalyptus does ‘silent dismissals’
The company’s boss, Tim Doyle, defended its culture, saying its rapid growth required “structured performance management reviews”.
- Nick Bonyhady
- Exclusive
- Cancer
GenesisCare business comes back to life, won’t offset payments bungle
The collapsed cancer services group will likely split its US assets ahead of a sale.
- Updated
- Carrie LaFrenz and Jemima Whyte
HMC to launch global multibillion-dollar healthcare fund
HMC Capital’s David Di Pilla says healthcare real estate is supported by structural megatrends and is increasingly being targeted by institutional investors.
- Larry Schlesinger
Being an introvert helped set up this Young Rich Lister to make $1b
Alex Tomic didn’t find university challenging, so he quit. Now he’s worth $125 million and climbing, as the toothpaste-related company he formed with a childhood friend shines bright.
- Julie-anne Sprague
Why perfectly healthy people are paying $3900 for a full-body MRI
A younger, moneyed generation is funding a new wave of quantified health start-ups that promise elevated, individualised care powered by data and artificial intelligence.
- Elizabeth Dwoskin
Ares in the kennel for $1b-plus VetPartners auction
Street Talk can reveal the US investment giant is set to take on rivals EQT and Affinity in the Jefferies-run auction.
- Sarah Thompson, Kanika Sood and Emma Rapaport
Healthtech PainChek seeks equity injection
The $36 million ASX-listed company had Canaccord Genuity rounding up investors at 2.7¢ a pop.
- Sarah Thompson, Kanika Sood and Emma Rapaport
- Opinion
- Opinion
Aspiration for private health a test of Labor’s centrist credentials
The private health industry may be a bellwether regarding how well the government can retain its centrist reputation with the aspirational left.
- Tanveer Ahmed
It’s back: UK ramps up COVID jabs amid fears over Pirola variant
The “most concerning variant since omicron” spurs an early start, and more money, for England’s winter vaccination campaign.
- Hans van Leeuwen
